Last reviewed · How we verify

Placebo of Simvastatin

Tanabe Pharma Corporation · Phase 3 active Small molecule

Placebo of Simvastatin is a Small molecule drug developed by Tanabe Pharma Corporation. It is currently in Phase 3 development for Control arm in Phase 3 clinical trials of simvastatin (active comparator for hyperlipidemia/cardiovascular risk reduction).

This is a placebo control formulation used in clinical trials to compare against the active simvastatin drug and has no therapeutic mechanism.

This is a placebo control formulation used in clinical trials to compare against the active simvastatin drug and has no therapeutic mechanism. Used for Control arm in Phase 3 clinical trials of simvastatin (active comparator for hyperlipidemia/cardiovascular risk reduction).

At a glance

Generic namePlacebo of Simvastatin
SponsorTanabe Pharma Corporation
ModalitySmall molecule
Therapeutic areaCardiovascular
PhasePhase 3

Mechanism of action

A placebo is an inert substance administered in blinded clinical trials to serve as a control comparator. In this case, it is used in Phase 3 trials of simvastatin (an HMG-CoA reductase inhibitor) to evaluate the efficacy and safety of the active drug by comparing outcomes between placebo-treated and simvastatin-treated groups.

Approved indications

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Placebo of Simvastatin

What is Placebo of Simvastatin?

Placebo of Simvastatin is a Small molecule drug developed by Tanabe Pharma Corporation, indicated for Control arm in Phase 3 clinical trials of simvastatin (active comparator for hyperlipidemia/cardiovascular risk reduction).

How does Placebo of Simvastatin work?

This is a placebo control formulation used in clinical trials to compare against the active simvastatin drug and has no therapeutic mechanism.

What is Placebo of Simvastatin used for?

Placebo of Simvastatin is indicated for Control arm in Phase 3 clinical trials of simvastatin (active comparator for hyperlipidemia/cardiovascular risk reduction).

Who makes Placebo of Simvastatin?

Placebo of Simvastatin is developed by Tanabe Pharma Corporation (see full Tanabe Pharma Corporation pipeline at /company/tanabe-pharma-corporation).

What development phase is Placebo of Simvastatin in?

Placebo of Simvastatin is in Phase 3.

Related